Results 161 to 170 of about 9,225,670 (325)

Peptidylarginine deiminase: a candidate factor in demyelinating disease [PDF]

, 2002
M.A. Moscarello, Laura B. Pritzker, Fabrizio G. Mastronardi, D. D. Wood   +3 more
openalex   +1 more source

The balance between cathepsin C and cystatin F controls remyelination in the brain of Plp1‐overexpressing mouse, a chronic demyelinating disease model

Glia, 2017
Takahiro Shimizu, W. Wisessmith, Jiayi Li, M. Abe, K. Sakimura, B. Chetsawang, Y. Sahara, K. Tohyama, Kenji F. Tanaka, K. Ikenaka   +9 more
semanticscholar   +1 more source

Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Journal of the Peripheral Nervous System, Volume 30, Issue 4, December 2025.
ABSTRACT Background and Aims Previous studies suggest that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) experience impaired sleep, contributing to fatigue. Traditional methods like polysomnography or questionnaires are resource‐intensive and may not capture sleep in natural settings.
Jan Voth, Charlotte von Gall, Noëmi Gmahl, Noah M. Werner, Gerd Meyer zu Hörste, Sven G. Meuth, Marc Pawlitzki, Lars Masanneck   +7 more
wiley   +1 more source

Congestive myelopathy due to spinal dural arteriovenous fistula mimicking CNS demyelinating disease. [PDF]

J Cerebrovasc Endovasc Neurosurg, 2022
Kim N, Kim H, Kim H, Park J.
europepmc   +1 more source

TNFα: kill or cure for demyelinating disease? [PDF]

, 2002
Bente Finsen, Jack P. Antel, Trevor Owens   +2 more
openalex   +1 more source

AAV‐Based Intracerebral Administration of BDNF Promotes Myelin Repair and Cognitive Improvement After Cuprizone‐Induced Demyelination

Glia, Volume 73, Issue 11, Page 2189-2205, November 2025.
Main Points AAV‐BDNF improves cognitive performance after cuprizone‐induced demyelination. BDNF promotes OPC maturation and enhances remyelination in the corpus callosum. Mitochondrial integrity is preserved through reduced swelling and improved morphology.
Yousra El Ouaamari, Leonardo Ricciardi, Sanne van der Heijden, Antonia Peter, Jorrit De Waele, Jasper Van den Bos, Debby Van Dam, Elke Calus, Sarah Kuhn, Waleed Marei, Yvonne Dombrowski, Marleen Verhoye, Peter Ponsaerts, Inez Wens, Nathalie Cools   +14 more
wiley   +1 more source

Information Theory Analysis of CTX Shows Consistent Clinical Presentation

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Cerebrotendinous xanthomatosis (CTX) is a rare, metabolic disorder caused by pathogenic variants in CYP27A1. The classic clinical presentation includes infantile‐onset chronic diarrhea, juvenile‐onset bilateral cataracts, with development of tendon xanthomas and progressive neurological dysfunction.
Jennifer Hanson, Penelope E. Bonnen
wiley   +1 more source

Demyelinating Disease of the Central Nervous System Concurrent With COVID-19. [PDF]

Cureus, 2021
Karsidag S, Sahin S, Ates MF, Cinar N, Kendirli S.   +4 more
europepmc   +1 more source

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease

, 1990
Stephen D. Miller, S J Gerety, Mary K. Kennedy, Jeffrey D. Peterson, John L. Trotter, Vincent K. Tuohy, Carl Waltenbaugh, Mauro C. Dal Canto, Howard L. Lipton   +8 more
openalex   +1 more source

Aryl Hydrocarbon Receptor in Health and Disease

MedComm, Volume 6, Issue 11, November 2025.
Based on the structure and ligands of AhR, this review introduces the AhR‐related signaling pathways and their roles in health and diseases. Agonists and antagonists of AhR as well as new strategies for treatment using the microbial–AhR axis are summarized. A prospect was made for the future use of AhR as a therapeutic target.
Haonan Li, Yufeng Fan, Jizheng Liu, Shumin Dong, Bin Wen, Yunfei Zhang, Xiaocui Wang, Xuemei Duan, Ying Hu, Ze Yan, Huifeng Shang, Yukai Jing   +11 more
wiley   +1 more source